19–21 Nov 2026
"Alexandru Ioan Cuza" University of Iasi and "Gheorghe Asachi" Technical University of Iași
Europe/Bucharest timezone

A Dual-Path AI Architecture for Preliminary Lung Cancer Assessment from CT Images and Risk Factors

19 Nov 2026, 16:45
15m
Room 2

Room 2

Paper presentation Doctoral Symposium Doctoral Symposium

Speakers

Andrei Buhnici (National Univesity of Science and Technology POLITEHNICA Bucharest)Ms Denisa-Daniela Frimu-Pascu (National University of Science and Technology Politehnica Bucharest)

Description

Lung cancer remains a leading cause of cancer mortality, while timely assessment depends on access to imaging, specialized expertise, and efficient digital workflows. This paper presents a research prototype for preliminary lung-cancer assessment that combines two complementary machine-learning pathways within a modular web architecture. The first pathway classifies computed-tomography images as normal, benign, or malignant using an AlexNet-style convolutional neural network. The second estimates lung-cancer risk from questionnaire-derived demographic, behavioral, and symptom variables using logistic regression. The platform integrates an Angular client with a shared Flask model-inference service, separate Flask services for authentication, history, and notifications, PostgreSQL persistence, and Docker-based deployment. In the original proof-of-concept evaluation, the CT classifier achieved 98.8% accuracy with class-wise F1-scores of 0.98–0.99, while the questionnaire classifier achieved 94.4% accuracy and an F1-score of 0.95 for the lung-cancer class. The application reported model-processing time of approximately 150 ms. Because the original CT workflow used image-level splitting after augmentation, the image-classification result is treated here as internal proof-of-concept performance rather than patient-level clinical generalization. The work demonstrates how two heterogeneous AI pathways can share one model-inference service inside a modular, containerized platform while surrounding application services remain separately deployable. Patient-grouped validation, leakage-safe preprocessing, and external evaluation are priorities for future work.

Authors

Andrei Buhnici (National Univesity of Science and Technology POLITEHNICA Bucharest) Ciprian Dobre (National University of Science and Technology Politehnica Bucharest) Ms Denisa-Daniela Frimu-Pascu (National University of Science and Technology Politehnica Bucharest) Mr Mihai-Alexandru Filișanu (National University of Science and Technology Politehnica Bucharest)

Presentation materials